Autopsy report · NCT02130765

Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia

“Terminated due to low enrollment rate.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 months before it started.
• Ran for about 1 year 8 months before it stopped.
• 64 participants enrolled.
• Results were posted on the registry 2 years 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Abbott Medical Devices

Sponsor type

Industry

Conditions

Monomorphic Ventricular Tachycardia

Interventions

Cardiac catheter ablation with ICD/CRT-D

Participants

64

Sites

38

Countries

Australia, France, Italy, United Kingdom, United States

Trials that died the same way

• Prediction of REsponse to Depression Interventions (Accelerated rTMS) Using Clinical and TD-fNIRS Measurements
  “Terminated due to low enrollment.” (97% match in meaning)
• Non-invasive Measures of Effects of Xolair in Asthma
  “Terminated due to poor enrollment.” (95% match in meaning)
• Study to Determine the Utility of Wound Vacuum Assisted Closure (VAC) Compared to Conventional Saline Dressing Changes
  “terminated, due to lack enrollment,” (93% match in meaning)
• Study of Maternal Hepatitis C Infection and Influenza Vaccination in Pregnancy
  “Terminated due to lack of enrollment” (90% match in meaning)
• Polycystic Liver Disease in Kidney Transplant
  “Terminated due to inadequate enrollment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.